Skip to main content

Advertisement

SpringerLink
Log in

Cardiac Sarcoidosis: Diagnosis and Management

  • Valvular Heart Disease (AS Desai and PT O'Gara, Section Editors)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Cardiac sarcoidosis can be life threatening if not promptly diagnosed and treated appropriately and aggressively. The diagnosis of myocardial disease is often difficult and circumstantial because there are no reliable diagnostic tests. Except for the finding of noncaseating granulomas on endomyocardial biopsy, most tests are limited and nonspecific. Therefore, the decision of initiating treatment is based on the patient’s symptoms and the course of the disease, rather than on the presence of histologic confirmation. The goal of therapy is to prevent irreversible cardiomyopathy and to thwart the progression to heart transplantation. The mainstay of treatment is corticosteroids, although there are no large randomized trials analyzing corticosteroid use. The combination with other immunosuppressant agents, such as Methotrexate and Azathioprine, is initiated on the patient’s failing or experiencing severe side effects from corticosteroids. While there are small studies proving the efficacy of tumor necrosis factor-inhibitors in cardiac sarcoidosis, more experience with these agents is needed. Catheter ablation or placement of implantable devices is indicated prophylactically in patients with severe ventricular tachyarrhythmias. Heart transplantation should be considered in patients with severe heart failure refractory to medical therapy. This article focuses on the current diagnostic tests and treatment recommendations for cardiac sarcoidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. The pathology of pulmonary sarcoidosis: update. Ma Y, Gal A, Koss MN. Semin Diagn Pathol. 2007 Aug;24(3):150–61. Review. PMID: 17882899 [PubMed - indexed for MEDLINE]

  2. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004;83:315–34.

    Article  Google Scholar 

  3. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157:9.

    Article  PubMed  CAS  Google Scholar 

  4. Thomsen TK, Eriksson T. Myocardial sarcoidosis in forensic medicine. Am J Forensic Med Pathol. 1999;20:52.

    Article  PubMed  CAS  Google Scholar 

  5. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. 1993;103:253–8.

    Article  PubMed  CAS  Google Scholar 

  6. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study on fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976;278:455–69.

    Article  PubMed  CAS  Google Scholar 

  7. Iwai K, Sekiguti M, Hosoda Y, et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994;11:26–31.

    PubMed  CAS  Google Scholar 

  8. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119:167–72.

    PubMed  CAS  Google Scholar 

  9. Fleming HA. Sarcoid heart disease. Br Heart J 1974;36:54–68.

    Article  PubMed  CAS  Google Scholar 

  10. Roberts WC, McAllister Jr HA, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63:86–108.

    Article  PubMed  CAS  Google Scholar 

  11. Angomachalelis N, Hourzamanis A, Salem N, et al. Pericardial effusion concomitant with specific heart musle disease in systemic sarcoidosis. Postgrad Med J. 1994;70 Suppl 1:S8–S12.

    PubMed  Google Scholar 

  12. Garret J, O’Neill H, Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J. 1984;107:394.

    Article  Google Scholar 

  13. Israel RH, Poe RH. Massive pericardial effusion in sarcoidosis. Respiration. 1994;61:176–80.

    Article  PubMed  CAS  Google Scholar 

  14. Verkleeren JL, Glover MU, Bloor C, et al. Cardiac tamponade secondary to sarcoidosis. Am Heart J. 1983;106:601–3.

    Article  PubMed  CAS  Google Scholar 

  15. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J. 2005;25:783–8.

    Article  PubMed  CAS  Google Scholar 

  16. Handa T, Uozato H, Higa R, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest. 2006;129:1246–52.

    Article  PubMed  Google Scholar 

  17. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax. 2006;61:68–74.

    Article  PubMed  CAS  Google Scholar 

  18. Hiraga, H, Yuwai, K, Hiroe, M, et al. Guidelines for the diagnosis of cardiac sarcoidosis: Study Report of Diffuse Pulmonary Diseases. The Japanese Ministry of Health and Welfare 1993; pp. 23–24

  19. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45:1683.

    Article  PubMed  Google Scholar 

  20. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299–302.

    Article  PubMed  CAS  Google Scholar 

  21. Ratner SJ, Fenoglio JJ, Ursell P. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest. 1986;90:528–33.

    Article  PubMed  CAS  Google Scholar 

  22. Silverman KJ, Hutchins GM, Buckley BH. Cardiac Sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204–11.

    Article  PubMed  CAS  Google Scholar 

  23. Suzuki T, Kanda T, Kubota S, et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest. 1994;106:1021.

    Article  PubMed  CAS  Google Scholar 

  24. Kinney EL, Jackson GL, Reeves WC, et al. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction: an analysis of 44 patients. Am J Med. 1980;68:497–503.

    Article  PubMed  CAS  Google Scholar 

  25. Fahy GJ, Marwick T, McCreery CJ, et al. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest. 1996;109:62–6.

    Article  PubMed  CAS  Google Scholar 

  26. Burstow DJ, Tajik AJ, Bailey KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol. 1989;63:478–82.

    Article  PubMed  CAS  Google Scholar 

  27. Lewin RF, Mor R, Spitzer S, et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J. 1985;110:116–22.

    Article  PubMed  CAS  Google Scholar 

  28. Bulkley BH, Rouleau JR, Whitaker JQ, et al. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest. 1977;72:27–32.

    Article  PubMed  CAS  Google Scholar 

  29. Haywood LJ, Sharma OP, Siegel ME, et al. Detection of myocardial sarcoidosis by thallium-201 imaging. J Natl Med Assoc. 1982;74:959.

    PubMed  CAS  Google Scholar 

  30. Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial defects in patients with sarcoidosis. Am J Med. 1988;85:189–93.

    Article  PubMed  CAS  Google Scholar 

  31. Mañá J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med. 1997;18:799.

    Article  PubMed  Google Scholar 

  32. Le Guludec D, Menad F, Faraggi M, et al. Myocardial sarcoidosis: clinical value of technetium-99m sestamibi tomoscintigraphy. Chest. 1994;106:1675–168.

    Article  PubMed  Google Scholar 

  33. Eguchi M, Tsuchihashi K, Hotta D, et al. Technetium 99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology. 2000;94:193–9.

    Article  PubMed  CAS  Google Scholar 

  34. Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995;107:330.

    Article  PubMed  CAS  Google Scholar 

  35. Kiuchi S, Teraoka K, Koizumi K, et al. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation. Int J Cardiovasc Imaging. 2007;23:237.

    Article  PubMed  Google Scholar 

  36. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol. 2005;185:110–5.

    PubMed  Google Scholar 

  37. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med. 2001;110:520.

    Article  PubMed  CAS  Google Scholar 

  38. Matsuki M, Matsuo M. MR findings of myocardial sarcoidosis. Clin Radiol 2000;55:323–5.

    PubMed  Google Scholar 

  39. Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest. 2005;128:1629.

    Article  PubMed  Google Scholar 

  40. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest. 2002;122:1895.

    Article  PubMed  Google Scholar 

  41. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969.

    Article  PubMed  Google Scholar 

  42. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med. 2003;44:1030–6.

    PubMed  Google Scholar 

  43. Butany J, Bahl NE, Morales K, et al. The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol. 2006;15:222.

    Article  PubMed  Google Scholar 

  44. Takada K, Ina Y, Yamamoto M, et al. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis. 1994;11:113.

    PubMed  CAS  Google Scholar 

  45. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006.

    Article  PubMed  CAS  Google Scholar 

  46. du Bois RM. Corticosteroids in sarcoidosis: friend or foe? Eur Respir J. 1994;7:1203.

    Article  PubMed  Google Scholar 

  47. Baughman RP, Sharma OP, Lynch III JP. Sarcoidosis: is therapy effective? Semin Respir Infect. 1998;13:255–73.x

    PubMed  CAS  Google Scholar 

  48. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155:846–51. doi:10.1001/archinte.155.8.846.

    Article  PubMed  CAS  Google Scholar 

  49. Webster GF, Razsi LK, Sanchez M, et al. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol. 1991;24:451–4.

    Article  PubMed  CAS  Google Scholar 

  50. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax. 1999;54:742–6.

    Article  PubMed  CAS  Google Scholar 

  51. Pacheco Y, Marechal C, Marechal F, et al. Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis. 1985;2:107.

    PubMed  CAS  Google Scholar 

  52. Müller-Quernheim J, Kienast K, Held M, et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J. 1999;14:1117.

    Article  PubMed  Google Scholar 

  53. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18:70.

    PubMed  CAS  Google Scholar 

  54. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174:795.

    Article  PubMed  CAS  Google Scholar 

  55. Rossman MD, Newman LS, Baughman RP, et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23:201.

    PubMed  Google Scholar 

  56. Doty JD, Mazure JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127:1064–71.

    Article  PubMed  CAS  Google Scholar 

  57. Roberts SD, Wilkes DS, Burgett RA, Knox KS. Refractory sarcoidosis responding to infliximab. Chest. 2003;124:2028–31.

    Article  PubMed  Google Scholar 

  58. Uthman I, Touma Z, Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol. 2007;26:2001–3.

    Article  PubMed  Google Scholar 

  59. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol. 1993;16:462–72.

    Article  PubMed  CAS  Google Scholar 

  60. Ahmad K, Kim YH, Spitzer AR, et al. Total nodal radiation in progressive sarcoidosis. Case report Am J Clin Oncol. 1992;15:311.

    CAS  Google Scholar 

  61. Jefic D, Joel B, Good E, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm. 2009;6:189.

    Article  PubMed  Google Scholar 

  62. Bohnen M, Stevenson WG, Tedrow UB, et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. 2011;8(11):1661.

    Article  PubMed  Google Scholar 

  63. Kay GN, Epstein AE, Dailey SM, Plumb VJ. Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients. J Cardiovasc Electrophysiol. 1993;4(4):371.

    Article  PubMed  CAS  Google Scholar 

  64. Chen SA, Chiang CE, Tai CT, et al. Complications of diagnostic electrophysiologic studies and radiofrequency catheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center. Am J Cardiol. 1996;77(1):41.

    Article  PubMed  CAS  Google Scholar 

  65. Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol. 2000;23(6):1020.

    Article  PubMed  CAS  Google Scholar 

  66. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94:1585–91.

    Article  PubMed  CAS  Google Scholar 

  67. Strickberger SA, Man KC, Daoud EG, et al. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation. 1997;96:1525–31.

    Article  PubMed  CAS  Google Scholar 

  68. Crandall MA, Bradley DJ, Packer DL, Asirvatham SJ. Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc. 2009;84:643–62.

    PubMed  Google Scholar 

  69. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol. 1991;18:937.

    Article  PubMed  CAS  Google Scholar 

  70. Bajaj AK, Kopelman HA, Echt DS. Cardiac sarcoidosis with sudden death: treatment with the automatic implantable cardioverter defibrillator. Am Heart J. 1988;116:557.

    Article  PubMed  CAS  Google Scholar 

  71. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1.

    Article  PubMed  Google Scholar 

  72. Wood MA, Ellenbogen KA. Cardiology patient pages. Cardiac pacemakers from the patient’s perspective. Circulation. 2002;105(18):2136.

    Article  PubMed  Google Scholar 

  73. Zaidi AR, Zaidi A, Vaitkus PT. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant. 2007;26:714.

    Article  PubMed  Google Scholar 

  74. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant. 1987;6:244–50.

    PubMed  CAS  Google Scholar 

  75. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant. 1992;11:367.

    PubMed  CAS  Google Scholar 

  76. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant. 2009;28(10):1007.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Division of Pulmonary and Critical medicine, Keck School of Medicine of USC, Los Angeles, CA, USA

    Michelle Bussinguer MD & Om P. Sharma MD, FRCP, Master FCCP, FACP

  2. Division of Cardiology, University of Connecticut Health Center, Farmington, CT, USA

    Alfred Danielian MD

Authors
  1. Michelle Bussinguer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfred Danielian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Om P. Sharma MD, FRCP, Master FCCP, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michelle Bussinguer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bussinguer, M., Danielian, A. & Sharma, O.P. Cardiac Sarcoidosis: Diagnosis and Management. Curr Treat Options Cardio Med 14, 652–664 (2012). https://doi.org/10.1007/s11936-012-0208-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-012-0208-3

Keywords

Search

Navigation